A phase 1/2 study of ixazomib in place of bortezomib or carfilzomib in a subsequent line of therapy for patients with multiple myeloma refractory to their last bortezomib or carfil... von Daniely, David, Forouzan, Eli, Spektor, Tanya M., Cohen, Alexa, Bitran, Jacob D., Chen, Gigi, Moezi, Mehdi M., Bessudo, Alberto, Hrom, John, Eshaghian, Shahrooz, Swift, Regina A., Eades, Benjamin M., Kim, Clara, Lim, Stephen, Berenson, James R.

Volltext

Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial von Nabhan, Chadi, Lestingi, Timothy M, Galvez, Angel, Tolzien, Kathy, Kelby, Susan K, Tsarwhas, Dean, Newman, Steven, Bitran, Jacob D

Volltext

Efficacy and safety of clofarabine in relapsed and/or refractory non‐hodgkin lymphoma, including rituximab‐refractory patients von Nabhan, Chadi, Davis, Nancy, Bitran, Jacob D., Galvez, Angel, Fried, Walter, Tolzien, Kathy, Foss, Susan, Dewey, Wendy M., Venugopal, Parameswaran

Volltext

Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment von Vidisheva, Aleksandra P., Wang, James, Spektor, Tanya M., Bitran, Jacob D, Lutzky, Jose, Tabbara, Imad A., Ye, Joseph Z., Ailawadhi, Sikander, Stampleman, Laura V., Steis, Ronald G., Moezi, Mehdi M., Swift, Regina A., Maluso, Tina M, Udd, Kyle A, Eshaghian, Shahrooz, Nassir, Youram, Berenson, James R.

Volltext

Disclosing the cancer diagnosis:the myth and the truth von Nabhan, Chadi, Bitran, Jacob D, Moore, 3rd, Clint

Volltext

Identifying predictors of equitable gender representation among hematology and oncology fellowship programs von Pandravada, Sasirekha, Mylavarapu, Praneet, Bitran, Jacob D.

Volltext

Role of Sorafenib in Overcoming Resistance of Chemotherapy-Failure Castration-Resistant Prostate Cancer von Meyer, Andrew, Cygan, Peter, Tolzien, Kathy, Galvez, Angel G, Bitran, Jacob D, Lestingi, Timothy M, Nabhan, Chadi

Volltext

A phase II pilot trial investigating the efficacy and activity of single agent granulocyte macrophage colony-stimulating factor as maintenance approach in castration - resistant pr... von Nabhan, Chadi, Meyer, Andrew, Tolzien, Kathy, Bitran, Jacob D, Lestingi, Timothy M

Volltext

A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma: A Report from the CIBMTR von Lazarus, Hillard M, Zhang, Mei-Jie, Carreras, Jeanette, Hayes-Lattin, Brandon M, Ataergin, Asli Selmin, Bitran, Jacob D, Bolwell, Brian J, Freytes, César O, Gale, Robert Peter, Goldstein, Steven C, Hale, Gregory A, Inwards, David J, Klumpp, Thomas R, Marks, David I, Maziarz, Richard T, McCarthy, Philip L, Pavlovsky, Santiago, MD, Rizzo, J. Douglas, Shea, Thomas C, Schouten, Harry C, Slavin, Shimon, Winter, Jane N, van Besien, Koen, Vose, Julie M, Hari, Parameswaran N

Volltext

Idiopathic Erythrocytosis: Vascular Complications von Malas, Abdullah, Bufalino, Shams, Hancock, Christie, Bitran, Jacob D.

Volltext

Thalidomide and dexamethasone for newly diagnosed multiple myeloma: is this really the standard of care? von Nabhan, Chadi, Bitran, Jacob D

Volltext

Are double-hit lymphoma patients being adequately evaluated for CNS disease? von Hancock, Christie, Bitran, Jacob D., Almanaseer, Imad, Green, Angel

Volltext

Is Initial Dasatinib-Blinatumomab Therapy for Ph-Positive ALL in Adults Cost Effective? von Bitran, Jacob D., Nabrinsky, Edward, Bufalino, Shams, Knouse, Phillip, Galvez, Angel G.

Volltext

A retrospective study of double-hit lymphomas in elderly patients (> 70 years): Overall outcomes von Hancock, Christie, Knouse, Phillip, Almanaseer, Imad, Bitran, Jacob D.

Volltext

Quantitating incremental value in oncology von Bitran, Jacob D., Hancock, Christie, Green, Linda, Lestingi, Timothy M.

Volltext

Erlotinib in Lung Cancer von Nabhan, Chadi, Bitran, Jacob D

Volltext

Chronic lymphocytic leukemia: to transplant or not to transplant... that is the question? von Nabhan, Chadi, Bitran, Jacob D

Volltext

Medicare compared with private insurance for the treatment of cancer von Martinez-Knouse, Phillip, Hancock, Christie, Nabrinsky, Edward, Lestingi, Timothy M., Bitran, Jacob D.

Volltext

REPOCH compared with RCHOP for the treatment of diffuse large B-cell lymphoma of activated B-cell type von Martinez-Knouse, Phillip, Nabrinsky, Edward, Chandran, Anjana, Lestingi, Timothy M., Bitran, Jacob D.

Volltext

Reducing Unwarranted Oncology Care Variation Across a Clinically Integrated Network: A Collaborative Physician Engagement Strategy von Richards, Jon M, Burgon, Trever B, Tamondong-Lachica, Diana, Bitran, Jacob D, Liangco, Wilfredo L, Paculdo, David R, Peabody, John W

Volltext